Donate For Public and Patients Store Search

American Academy of Dermatology Logo
Welcome!

DW Weekly

Dermatology World Weekly is a brief, concise digest of the latest news, hand-picked by DW’s editorial team with analysis of why it matters to dermatologists.

Each week editors review the landscape of health care news in DW's core areas of practice management, policy, and patient care, and highlight a few stories with links to AAD resources that provide more context and opportunities to act. If you read the news and wonder, "What does this mean for me?" — DW Weekly is for you.

Read the latest issues below. Let us know if you see a story you'd like us to cover at dweditor@aad.org.

2019 issues

Nov. 6 & 13, 2019

Nov. 13, 2019:

  • New recommendations for detecting noninvasive melanoma published

  • DW Insights and Inquiries: The naked truth about total body skin examination — A lesson from Goldilocks and the Three Bears

  • Apply or nominate a colleague for Advocate of the Year

  • Health Affairs highlights dermatologist voices in new series

  • New Medicare card transition period ending

  • MIPS extreme and uncontrollable circumstances policy expands to new areas

Nov. 6, 2019:

  • SPF 50+ vs. 100+ — is there a difference?

  • DW Insights and Inquiries: Getting the gist of GIST cutaneous hyperpigmentation disease

  • Academy announces new Executive Director and CEO

  • Academy releases joint guidelines for psoriasis in pediatric patients

  • AAD/A members vote to remove Board member

  • Join the Academy’s Skin Cancer Measure Testing Project

  • Federal report addresses drug shortage causes, potential solutions

Oct. 23 & 30, 2019

October 30, 2019:

  • Potential treatment for chronic urticaria may offer complete control

  • DW Insights and Inquiries: Can chowing down improve pseudoxanthoma elasticum?

  • Advances in medical technology: friend or foe?

  • Do U.S. dermatology residents suffer from imposter syndrome?

  • Syphilis and STDs on the rise for fifth year in a row

October 23, 2019:

  • Treating molluscum contagiosum: Ingenol mebutate vs. imiquimod

  • DW Insights and Inquiries: Coming clean on bleach baths for atopic dermatitis

  • Ancestry launches consumer genetic health testing

  • CMS offers new MIPS resources

  • Florida bill proposes requiring prescriptions for sunscreens that could harm coral reefs

  • World Psoriasis Day is approaching

Oct. 2, 9 & 16, 2019

October 16, 2019:

  • Is there a link between lupus and prescription opioids?

  • DW Insights and Inquiries: Nonepidemic Kaposi sarcoma: The fifth dimension

  • Academy cautions members of fraudulent email solicitations promoting sale of AAD’s Annual Meeting attendee list

  • Updated AAD.org puts most-used content at members’ fingertips

  • GAO interviews Academy experts on sunscreen safety testing

  • New Medicare card transition period ending

  • AAD diversity workshop addresses disparities in dermatology

October 9, 2019:

  • Topical calcineurin inhibitors vs. topical corticosteroids for vitiligo

  • DW Insights and Inquiries: Glucose monitors — Not as sweet as they seem

  • American Board of Dermatology announces alternative to MOC exam

  • Upcoming coding changes: Differentiating intermediate from complex repairs

  • Academy supports legislation that would ensure patient access to medication

  • Virtual group election period open for MIPS 2020 performance period

  • President Trump executive order calls for sweeping changes to Medicare Advantage

October 2, 2019:

  • Does gluten increase risk for psoriasis and AD in women?

  • DW Insights and Inquiries: Cutting giant congenital nevi down to size molecularly

  • Upcoming coding changes: Differentiating intermediate from complex repairs

  • Apple cider vinegar soaks to treat AD: Yea or nay?

  • Which dermatologic conditions have the highest hospital readmission rates...and what's the cost

Sept. 18 & Sept. 25, 2019

September 25, 2019:

  • Which biologics cause weight gain in psoriasis patients?

  • DW Insights and Inquiries: I never wanted chaperones — until now

  • Two sides to every story

  • Academy's contribution to skin cancer prevention shows nationwide progress  

  • Physician burnout is real, but AADA's DERM360 resources can help 

  • Quinacrine dihydrochloride recalled by Darmerica

  • Nominations sought for 2020 Academy election

September 18, 2019:

  • HPV vaccine to treat common warts?

  • DW Insights and Inquiries: Calcipotriene and 5-fluorouracil — Dermatology’s new dynamic duo?

  • Government green-lights co-pay accumulator programs for 2020

  • Howard Rogers, MD, testifies to House committee about prior authorization burdens

  • Hurricane Barry triggers MIPS extreme and uncontrollable circumstances policy

  • Medicare Beneficiary Identifier (MBI) transition period nearing its end

Sept. 4 & Sept. 11, 2019

September 11, 2019:

  • How often do dermatologists prescribe off-label medications?

  • DW Insights and Inquiries: Shingles and the battle of the bulge

  • Feedback requested: AAD/NPF draft guidelines for the management of psoriasis with non-biologics

  • Deadline approaching to submit a 2018 MIPS targeted review request

  • FDA expands approval of two topical psoriasis therapies to pediatric patients

  • Grants available for technology-based teaching applications

September 4, 2019

  • New Drug Application submitted for rosacea topical treatment

  • DW Insights and Inquiries: Parabens — A common allergen with lots of hype and no real harm

  • Feedback requested: AAD/NPF draft guidelines for the management of psoriasis with non-biologics

  • AAD media coverage on sun protection earns one billion media impressions

  • Nominations sought for 2020 Academy election

Aug. 21 & Aug. 28, 2019

August 28, 2019:

  • Dupilumab shows positive results for younger atopic dermatitis patients

  • DW Insights and Inquiries: Finding joy in pediatric phototherapy

  • FDA, UMD seek feedback on compounded drug use

  • California, New York ban discrimination against natural hair

  • Grants available for technology-based teaching applications

August 21, 2019:

  • FDA grants breakthrough therapy designation to advanced melanoma treatment

  • DW Insights and Inquiries: Rejecting preconceived notions of squamous cell carcinomas in patients experiencing transplant rejections

  • Quality Payment Program hardship exemption applications now available

  • New hidradenitis suppurativa guidelines highlight disease complexity

  • Submit an abstract for the Gross and Microscopic Symposium

Aug. 7 & Aug. 14, 2019

August 14, 2019:

  • CMS seeks to reduce prior authorization burden on physicians

  • DW Insights and Inquiries: Putting muscle into isotretinoin laboratory testing isn’t chopped liver!

  • Applicants sought for research excellence awards for young dermatology investigators

  • Medicare Beneficiary Identifier (MBI) transition period nearing its end

  • Nominations sought for 2020 Academy election

August 7, 2019:

  • What effect has iPLEDGE had on pregnancy rates?

  • DW Insights and Inquiries: Snitching on Schnitzler syndrome — The continuing search for an optimal biomarker

  • U.S. Virgin Islands bans sunscreen with oxybenzone and octinoxate

  • Joint clinical guidelines provide evidence-based practices for treating psoriasis 

  • Submit an abstract for the Gross and Microscopic Symposium

July 24 & July 31, 2019

July 31, 2019:

  •  Academy and NPF release new psoriasis phototherapy guidelines

  • DW Insights and Inquiries: A metabolic pathway that may allow dermatologists to run rings around porokeratoses

  • Having trouble finding diphenylcyclopropenone?

  • Submit an abstract for the Gross and Microscopic Symposium

  • Nominations sought for 2020 Academy election

July 24, 2019:

  • Wound care after dermatologic procedures lacks uniformity

  • DW Insights and Inquiries: Eosinophilic dermatosis of hematologic malignancy: Reality bites

  • A look back at dermatology’s past with an eye on the future

  • A customized vaccine for advanced melanoma?

  • Call for nominations for 2020 AAD election

  • House votes to repeal ‘Cadillac Tax’

  • Sheila F. Friedlander, MD, to present on dermal absorption at Univ. of Maryland School of Pharmacy workshop

July 3, July 10 & July 17, 2019

July 17, 2019:

  • Isotretinoin, depression, and suicide: What’s the connection?

  • DW Insights and Inquiries: Should dermatologists be anti-antihistamine for atopic dermatitis?

  • 2018 MIPS performance feedback, final score, and targeted review now available

  • Natural skin care regimen vs. synthetic regimen for managing rosacea

  • Two more speakers confirmed for 2019 AADA Legislative Conference

July 10, 2019:

  • FDA clears new body sculpting device

  • DW Insights and Inquiries: The pachydermoperiostosis prostaglandin paradigm

  • Increase in demand triggers shortage of intravenous immunoglobulin

  • Patient Access Hero: Dallas clinic provides free multidisciplinary care

  • Miami Beach Commission Sustainability and Resiliency Committee rejects sunscreen ingredient ban

July 3, 2019:

  • Academy comments on FDA sunscreen proposal

  • DW Insights and Inquiries: Oy, another “Oid” to worry about — cryptococcoid lesions

  • VA launches Community Care Network to provide better access to care

  • CMS has begun MIPS data validation, audits for 2017 and 2018 performance years

  • What happened at the AMA House of Delegates meeting? Private equity, compounding, and more.

  • CMS proposes Medicare Part D electronic prior authorization standards

June 19 & June 26, 2019

June 26, 2019:

  • CMS/NCCI changes to PTP edits go into effect next week

  • DW Insights and Inquiries: Conceptualizing atypical fibroxanthomas, pleomorphic dermal sarcomas, and undifferentiated pleomorphic dermal sarcomas

  • Beyond the specialty: How AccessDerm helps primary care providers

  • How do melanoma patients view skin self-examinations?

  • Delaware governor signs critical step therapy bill

June 19, 2019:

  • Do hidradenitis suppurativa patients have a greater comorbidity burden than psoriasis patients?

  • DW Insights and Inquiries: The newest frontier for biologics and psoriasis may be adherence

  • Complimentary webinar: FDA's proposed sunscreen rule — what safety data is the FDA looking for and why?

  • Private equity by the numbers

  • Media personality Michael Smerconish will offer keynote at 2019 AADA Legislative Conference

  • 2020 committee appointment application now open

June 5 & June 12, 2019

June 12, 2019:

  • A new way to treat warts? Heat may be the answer.

  • DW Insights and Inquiries: Taking the challenge: Social media, adolescents, and the skin

  • Dollars and cents: What’s the cost of physician burnout?

  • CMS seeks input for reducing administrative, regulatory burdens

June 5, 2019:

  •  Self-injection of black market dermal fillers poses health concern

  • DW Insights and Inquiries: Stress2 + Hormones2 = Acne2

  • CMS/NCCI announce changes to PTP edits

  • New survey highlights impact of local anesthetics shortage

  • FDA approves first treatment for graft versus host disease

  • What’s the direct liability for business associates under HIPAA?

  • 2020 committee appointment application now open

     

May 22 & May 29, 2019

May 29, 2019:

  • Academy issues statement on sunscreen safety

  • DW Insights and Inquiries: Life is just a bowl of cherry angiomas

  • AccessDerm: Serving the underserved

  • Anthem enforces modifier 25 denials

  • New resolution paves the way for sunscreen in schools and sun-safe education for kids

  • Kaposi sarcoma treatment gets Breakthrough Therapy designation

  • Patient Care Hero: Could a skin rash provide a clue to this woman’s diagnosis

  • Academy Advisory Board invites members to submit policy resolutions

May 22, 2019:

  • What's happening to practice ownership?

  • DW Insights and Inquiries: Breaking the terbinafine laboratory habit for onychomycosis

  • Do you know how to get to 30 points to avoid a MIPS penalty?

  • Augmented intelligence: The synergy of man and machine to improve patient care

  • Maryland passes under-18 indoor tanning ban

  • CMS takes action to lower prescription drug prices, increase transparency

May 1, May 8 & May 15, 2019

May 15, 2019:

  • Why are psoriasis patients turning to complementary and alternative medicine?

  • DW Insights and Inquiries: Coughing up a new warning for ustekinumab

  • AAD adopts position statement on sexual and gender minority health

  • HHS finalizes rule requiring drug prices to be disclosed in TV ads

  • A cheat sheet to dermatology’s ‘hidden curriculum’ 

  • Dr. Resneck testifies to Congress about drug prices and prior authorization

  • Register for the 2019 AADA Legislative Conference 

  • Academy Advisory Board invites members to submit policy resolutions

May 8, 2019:

  • Skin scratching and intestinal changes: What’s the link?

  • DW Insights and Inquiries: Progress for progressive multifocal leukoencephalopathy

  • New maximum penalties for HIPAA violations

  • Adopt-a-Shade: Working together

  • Teledermatology templates decrease face-to-face referrals

May 1, 2019:

  • FDA approves risankizumab for treatment of plaque psoriasis

  • DW Insights and Inquiries: When assessing morbilliform eruptions think about morbilli (measles)!

  • We want your feedback: Draft psoriasis guidelines for pediatric patients

  • CMS to allow insurers to adopt copay accumulators

  • 3 ways to promote skin cancer awareness this month

  • Preliminary MIPS performance data now available

  • Members of Congress take on sunscreen use

  • NIH to honor dermatologist Stephen I. Katz, MD, PhD, on May 3

  • 2020 committee appointment application now open

April 17 & April 24, 2019

April 24, 2019:

  • Dermal filler may effectively treat facial acne scarring

  • DW Insights and Inquiries: Fever, rash, and lymphadenopathy may be wearing more than one DRESS

  • AAD Board of Directors shed light on the strategic plan’s impact on members

  • Feedback requested: Draft psoriasis guidelines for pediatric patients

  • Deadline to review QPP performance data April 27

  • 2020 committee appointment application now open

April 17, 2019:

  • Having trouble accessing compounded quinacrine tablets? Here’s why.

  • DW Insights and Inquiries: A ‘pregnant pause’ is necessary before concluding on the obstetric risk of vitiligo

  • Lessons learned from the customer service world

  • Let’s talk about leading care teams and other elephants in the room

  • Who are the happiest dermatologists? New survey results have answers.

  • NIH to honor dermatologist Stephen I. Katz, MD, PhD, on May 3

  • Academy committee volunteers need to update their disclosures

April 3 & April 10, 2019

April 10, 2019:

  •  ‘Inactive’ ingredients in pills may cause allergic reaction

  • DW Insights and Inquiries: Is there a best approach to widespread actinic keratoses?

  • What’s the optimal way to perform total body skin examinations?

  • Study shows medical spa oversight needs improvement

  • Deadline to review QPP performance data April 27

April 3, 2019

  • Can the elimination diet hurt pediatric atopic dermatitis patients?

  • DW Insights and Inquiries: Tofacitinib – a JAK inhibitor of all trades

  • Unity in dermatology starts with putting patients first 

  • Acne risk in transgender men treated with testosterone

  • Ixekizumab sustains plaque psoriasis improvements, quality of life for one year

  • American Academy of Dermatology announces Interim Executive Director

March 20 & March 27, 2019

March 27, 2019

  • Academy forms task force to address FDA proposed rule on sunscreen monograph, ingredients

  • DW Insights and Inquiries: Biting my nails worrying about atypical presentations of nail unit melanomas

  • Real-time patient data transforms the practice and improves care

  • Joint position statement educates policymakers on safe in-office preparation of buffered lidocaine by dermatologists

  • Patient Care Heroes: Carrie Kovarik, MD, and Keith Hamilton, MD

March 20, 2019:

  • Sodium bicarbonate injection recalled due to presence of glass

  • DW Insights and Inquiries: Dermatologists will increasingly meet mammalian meat allergy

  • Diversifying the specialty can result in high-quality access to dermatologic care

  •  Trouble getting off-label meds? Flawed compendia causing coverage denials for dermatologic conditions

  • Miami Beach commissioners vote ‘no’ on sunscreen ingredient prohibition

March 6 & March 13, 2019

March 13, 2019:

  • Is routine laboratory monitoring for isotretinoin patients necessary?

  • Welcome to Dermatology World Insights and Inquiries

  • Innovative learning experiences equip members to provide compassionate patient care

  • Scientists report curing HIV-positive patient for a second time

  • Hidradenitis suppurativa linked to cardiovascular disease

  •  FDA statement discusses plan for naming biological medicines

March 6, 2019:

  • FDA approves self-injection of guselkumab for plaque psoriasis 

  • Nearly 80% of public find drug prices 'unreasonable'

  • Biotin supplementation unnecessary for most patients, may lead to misdiagnosis

  • Why are academic dermatologists burned out?

Feb. 20 & Feb. 27, 2019

February 27, 2019:

  • FDA approves new neurotoxin for frown lines

  • Breaking down the FDA’s new sunscreen proposal 

  • Update on Anthem instituting new modifier 25 payment policy

  • A new way to help diagnose allergic versus irritant contact dermatitis

  • Dermatologists concerned over use of equine medicine to treat rosacea

  • AAD and NPF release new guideline for treatment of psoriasis with biologics

  • Skin biopsy rate: An assessment of provider utilization

February 20, 2019:

  • Biologics may help fight heart disease in psoriasis patients

  • AAD mourns the passing of Richard L. Dobson, MD

  • Feedback requested: AAD joint guideline for reconstruction after skin cancer resection

  • Severe atopic dermatitis guidelines developed

  • Private payer issues with new biopsy codes

  • Tool may help predict melanoma recurrence after negative SNB

  • View candidates and ballot book online

Feb. 6 & Feb. 13, 2019

February 13, 2019:

  • Do biologics have more adverse events than conventional therapies? Researchers say 'No.'

  • AAD Strategic Plan driven by member feedback

  • Feedback requested: AAD/ASPS joint guideline for reconstruction after skin cancer resection

  • Medicare Administrative Contractors (MACs) deny Mohs with IHC claims

  • Academy leaders convene on Capitol Hill for first Academy Leadership Day

  • How much does having atopic dermatitis cost patients?

  • 2019 AAD Election ballot packet moved online

February 6, 2019

  • Nearly half of U.S. physicians are burned out

  • AAD/A CEO announces departure this spring

  • Anthem to institute new modifier 25 payment policy

  • Researchers create new protein that may help cancer patients

  • HHS proposes to end PBM rebate protections

  • Who has access to dermatology services?

  • NCCI and CMS address modifier 59 issues

  • 2019 AAD Election ballot packet moved online

Jan. 23 & Jan. 30, 2019

January 30, 2019:

  • Dermatologists prescribe fewer antibiotics overall, but use increased with surgery

  • CMS updates Open Payments data

  • What causes allergic responses in patients with atopic dermatitis?

  • YouTube videos about psoriasis biologics

  • Is a new type of treatment for alopecia on the horizon?

  • Palmetto GBA Jurisdiction J and M LCD #33445 affecting dermatology practices in several states

January 23, 2019:

  • How does skin age? Researchers may have found the answer.

  • AAD refutes misleading sunscreen article

  • Taking the pain out of prior authorization denials

  • Academy responds to Vision for the Future Commission draft report

  • NCCI and CMS address modifier 59 issues

  • Virginia Board of Medicine audits compounding practices

  • 2019 AAD Election ballot packet moved online 

Jan. 9 & Jan. 16, 2019

January 16, 2019:

  • Isotretinoin may change bacteria levels on skin of acne patients

  • Using DataDerm™ to seamlessly report for MIPS

  • We want your feedback: Psoriasis draft guidelines

  • Cochrane collection gathers new diagnostic test accuracy reviews for skin cancer

  • New guideline available for infantile hemangioma treatment

  • It’s time to use the new biopsy codes: Do you know how to use them?

  • Remembering Stephen I. Katz, MD, PhD

  • Academy Advisory Board invites members to submit policy resolutions

January 9, 2019:

  • Smartphone app improves treatment adherence for psoriasis patients

  • AAD mourns the passing of Stephen I. Katz, MD, PhD

  • Submit your comments on psoriasis draft guidelines

  • The Academy kicks off 2019 with a new Strategic Plan

  • Increased competition causes falling prices for infliximab and biosimilars

  • 2019 AAD Election ballot packet moved online

  • 2018 MIPS data submission period now open


2018 issues

December 2018

December 19, 2018:

  • A new frown line treatment – coming soon?

  • The AAD 2019 Strategic Plan: Our vision for the future

  • December Heroes: Jean Pierre Galliani, MD, and Naomi Johansen, MD

  • New guidelines issued for treating psoriatic arthritis

  • It’s almost time to use the new biopsy codes: Do you know to use them?   

December 12, 2018:

  • Trouble prescribing isotretinoin to new patients?

  • New tax bill would repeal indoor tanning tax

  • Are you smarter than DataDerm?™

  • Apply for the AAD’s Cochrane Scholarship

  • Academy Advisory Board invites members to submit policy resolutions

  • Keep dermatology’s voice strong: Join the AMA

December 5, 2018:

  • USP update on access to buffered lidocaine

  • Are you smarter than DataDerm™?

  • What’s the latest on drug shortages?

  • Identifying, treating rosacea in skin of color

  • 2019 AAD Election ballot packet moved online

November 2018

November 28, 2018:

  • A biologic for adolescent AD patients: Coming soon?

  • MIPS in 2019: Changes are coming

  • CMS seeks to implement real-time drug pricing widgets

  • Are you smarter than DataDerm™?

  • FDA attempting to get out ahead of drug shortages

  • Help the Academy keep dermatology’s voice strong: Join the AMA

  • CMS conducting new survey on post-op visits in global surgical codes

November 14, 2018:

  • 2019 Fee Schedule – You asked. DWW answers.

  • November Patient Care Hero: Jessica Burgy, MD

  • Are you smarter than DataDerm™?

  • CMS conducting new survey on post-op visits in global surgical codes

  • The MIPS results are in: How did participants perform in 2017?

  • FDA wants to hear from consumers about allergens and cosmetics

  • Dermatologist, pediatrician win congressional seats

November 7, 2018:

  • Fee Schedule: How will your practice fare in 2019?

  • Adopt-a-Shade: Giving kids a safe place to play

  • Academy releases guidelines for melanoma treatment

  • Are you smarter than DataDerm?

  • New psoriasis biologic now available in the United States

  • FDA to ban lead from hair products

Oct. 24 & Oct. 31, 2018

October 31, 2018:

  • Oral antibiotic gets FDA approval for acne

  • Teamwork Hero: Steven Daveluy, MD

  • ABMS approves Micrographic Dermatologic Surgery subspecialty

  • Are you smarter than DataDerm?

  • Trump administration announces plans to lower drug costs

  • Study: Topical tranexamic acid may be effective for erythematotelangiectatic rosacea

  • Older adults opt for fewer medications

October 24, 2018:

  • Drug shortages affecting your patients? Tell the FDA.

  • When dealing with payers, the data can speak for itself

  • Are you smarter than DataDerm™?

  • Adalimumab biosimilar launches in 28 countries

  • President Trump signs legislation prohibiting gag clauses

  • HHS calls for drug prices in television ads

Oct. 3, Oct. 10 & Oct. 17, 2018

October 17, 2018:

  • CMS to conduct new survey on post-op visits in global surgical codes

  • Are you smarter than DataDerm™?

  • ICD-10 updates impact several MIPS quality measures

  • CMS to waive Medicare requirements for providers affected by Hurricane Michael

  • Academy seeks statements on proposed bylaws amendments

  • Help the Academy keep dermatology’s voice strong: Join the AMA

October 10, 2018:

  • CMS to make physicians’ offices fax-free by 2020

  • Are you smarter than DataDerm™?

  • Issue breakdown: Compounding standard would disrupt care

  • AI trained to classify common dermatopathology diagnoses

  • AAD updates “Find a Dermatologist” tool — have you updated your profile?

  • Study suggests minority residents face extra workplace burdens

October 3, 2018:

  • Budget bill includes wins for dermatology

  • AAD updates “Find a Dermatologist” tool — have you updated your profile?

  • Are you smarter than DataDerm™?

  • Did CMS miscalculate your MIPS?

  • Perioral rejuvenation with hyaluronic acid fillers improved projected first impressions

Sept. 19 & Sept. 26, 2018

September 26, 2018

  • Drug prices spike after shortages

  • September Access Hero: Dr. Jonathan Silverberg

  • Dupilumab improves adolescent atopic dermatitis, quality of life

September 19, 2018

  • More than 25% of Americans surveyed think psoriasis is contagious

  • What did the AADA have to say about the proposed fee schedule?

  • Atopic dermatitis associated with depression, anxiety, and suicidal ideation

  • Have you joined the JAAD Journal Club yet?

  • Risk for surgical-site infection increased in lower extremity Mohs surgery

Sept. 5 & Sept. 12, 2018

September 12, 2018

  • CMS continues to tinker with MIPS in 2019 proposal

  • Experimental acne vaccine targets skin bacteria

  • Call for nominations deadline is Oct. 1

  • Hospitals launch generic drug company

  • Rosacea is drastically underdiagnosed, according to study

  • How effective are natural ingredients at UV protection?

  • Voice your opposition about repealing the indoor tanning tax

September 5, 2018

  • CMS values virtual visits

  • AMA House of Delegates votes on critical health policy resolutions 

  • High drug costs send patients seeking foreign medications

  • FDA approves tretinoin lotion for acne

  • Brief dermatologist intervention increases sunscreen use, patient satisfaction

Aug. 22 & Aug. 29, 2018

August 29, 2018

  • CMS questions global payment codes

  • Non-physician clinicians bill more dermatologic procedures

  • Can machine learning exacerbate health care disparities in dermatology?

  • Mediterranean diet may help ease psoriasis severity

  • Compounds in maple leaves may prevent wrinkles

August 22, 2018

  • 6 new biopsy codes for 2019

  • August Access Hero: Jessica Burgy, MD

  • Submit your comments on psoriasis draft guidelines

  • 2018 QPP exception applications now available

  • Ortho Dermatologics resubmits New Drug Application for plaque psoriasis lotion

Aug. 1, Aug. 8 & Aug. 15, 2018

August 15, 2018

  • The good, the bad, and the unknown in CMS E/M proposals 

  • DataDerm™: Better your practice, better the specialty

  • FDA approves new drug to treat cutaneous T-cell lymphoma

  • Dermatologist compensation growth stalls in 2017, survey shows

  • 2017 MIPS performance feedback and payment adjustment

  • Brent Moody, MD, wins Republican primary in Tennessee 

August 8, 2018

  • Fee schedule: The good, the bad, and the ugly 

  • August Access Hero: Cory Simpson, MD

  • USP publishes proposed revisions to chapter on compounded sterile preparations

  • CDC offers infection prevention guide as patient infection incidents increase

  • Severity of atopic dermatitis tied to risk of cataracts among pediatric patients

  • Tickborne diseases are likely to increase, warn NIH officials

August 1, 2018

  • Physicians suing patients over negative reviews

  • FDA to laser device manufacturers: Stop marketing for vaginal rejuvenation

  • FDA releases biosimilars plan to increase access, encourage competition

  • Blood test may be able to detect melanoma

  • Health care cyberattacks on the rise, sensitive data exposed

  • FDA grants orphan drug status to dermatomyositis drug

July 18 & July 25, 2018

July 25, 2018:

  • FDA takes steps to address, prevent drug shortages 

  • Distinction between inflammatory, neuropathic pruritus relevant for care

  • Melanoma underreported among dermatopathologists

  • Drugmakers rescind price hikes after California law takes effect

July 18, 2018:

  • FDA approves first topical hyperhidrosis treatment

  • CMS proposes major E/M changes, modifier 25 payment reduction: What’s next?

  • Survey indicates residents lack confidence in coding, billing skills

  • ‘Gag clauses’ cause some to pay more for drugs

  • Skin Cancer Prevention Report shows progress, room for improvement

  • Could the HPV vaccine treat squamous cell carcinoma?

  • FDA warns against use of sterile drug products 

July 4 & July 11, 2018

July 11, 2018:

  • Amazon upends drug market with purchase of online pharmacy

  • JAAD paper reviews research on chemical sunscreen and the environment

  • Clarification: FDA response to topical psoriasis treatment application

  • CMS posts 2017 Open Payments data

  • Novel targets, treatments needed for metastatic melanoma

  • FDA commissioner gives statement about compounded drugs

  • Trump administration threatens drug manufacturers 

July 4, 2018:

  • iPLEDGE hits a snag with patients

  • Hawaii governor signs legislation banning sunscreen with oxybenzone and octinoxate

  • Medicare announces new MUE limit for aminolevulinic acid HCI, 10%

  • How did you fare with MIPS in 2017? Take a look

  • FDA withdraws draft guidance on biosimilars

  • Is there a connection between HS and Crohn’s?

June 20 & June 27, 2018

June 27, 2018:

  • FDA does not approve topical psoriasis treatment

  • Medicare to limit reimbursement for aminolevulinic acid HCI, 10%

  • Senators urge FDA to examine drug shortages

  • Sen. Schumer works to pull ‘sunscreen pills’ from market

  • NEW: Urticaria guidelines

  • 2019 committee appointment application now open

June 20, 2018:

  • Robots in medicine are coming, but at what cost?

  • June Access Hero: Dr. Colven

  • Does benzoyl peroxide stain all fabrics?

  • CMS launches new Medicare Card search tool

  • Despite the risks, patients are willing to share their data

  • 2019 committee appointment application now open

June 6 & June 13, 2018

June 13, 2018:

  • FDA approves first hyaluronic acid filler for hands

  • Feedback requested: Primary cutaneous melanoma treatment draft guidelines

  • After 60 years, a new treatment for pemphigus vulgaris

  • Jack Resneck Jr., MD, re-elected to AMA Board of Trustees

  • Older patients slowly warming to telemedicine

  • 2019 committee appointment application now open

June 6, 2018:

  • Feedback requested: Primary cutaneous melanoma treatment draft guidelines

  • Integrating the human touch at the AAD Annual Meeting

  • Insurer reverses onerous isotretinoin policy

  • FDA issues REMS draft guidance for manufacturers

  • CMS releases QPP participation results

  • EB treatment receives rare pediatric disease designation from FDA

  • 2019 committee appointment application now open

May 23 & May 30, 2018

May 30, 2018:

  • FDA issues warning on unapproved sunscreen pills

  • May Access Hero: Karen Edison, MD

  • Study: AI detects skin cancer better than dermatologists

  • BCBS Michigan rescinds modifier 25 reimbursement reduction policy

  • Medical school enrollment is up, but can residency slots keep pace?

  • FDA approves new biologic for psoriasis

  • 2019 committee appointment application now open

May 23, 2018:

  • FDA declines to approve potential frown line treatment

  • AAD Annual Meetings: Vital to resident education and the future of dermatology

  • Dermatologist wins Republican nomination in Pennsylvania congressional primary race

  • VA gives physicians the green light to practice telemedicine across state lines

  • FDA eyeballs artificial intelligence in medicine

  • 2019 committee appointment application now open

May 2, May 9 & May 16, 2018

May 16, 2018:

  • Is your group eligible for MIPS? You’d better check.

  • Be a Skin Cancer Hero this May

  • AADA plans to comment on Trump drug-price proposals

  • Can technology help with treatment adherence?

  • 2019 committee appointment application now open

May 9, 2018:

  • FDA grants lidocaine HCL 1% approval to Spectra Medical

  • AAD Board selects Daniel D. Bennett, MD, as next assistant secretary-treasurer

  • Hawaii passes legislation banning sunscreen with oxybenzone and octinoxate

  • Study shows reduction of atrophic acne scars with adapalene 0.3%/benzoyl peroxide 2.5% gel

  • Academy Advisory Board invites members to submit policy resolutions

  • 2019 committee appointment application now open

May 2, 2018:

  • The clock is ticking: Only a few days left to review your Sunshine Act info

  • PBMs cutting copay coupons from patient deductibles — which could mean soaring prices for your biologics patients

  • The latest cosmetic trend: Preventative Botox

  • CMS to change name of MIPS EHR section

  • Want to know how much your patients’ prescriptions will cost? There’s an app for that.

  • 2019 committee appointment application now open

April 18 & April 25, 2018

April 25, 2018:

  • Who’s better at diagnosing skin cancer: PAs or dermatologists?

  • How is MIPS affecting you? CMS wants to know.

  • New physician compensation report: How does dermatology fare?

  • Medicare erroneously paid for telehealth services

  • 2019 committee appointment application now open

April 18, 2018:

  • Getting too many calls from pharmacists? It could get worse.

  • April Access Hero: Dr. Van Voorhees

  • 2019 committee appointment application now open

  • Not sure you’re eligible for MIPS? Better check.

  • Help wanted: AAD Pruritus Measure Testing Project

April 4 & April 11, 2018

April 11, 2018:

  • How did you fare with MIPS? Take a look.

  • Help wanted: AAD Pruritus Measure Testing Project

  • Indoor tanning bed users not getting screened

  • What is the economic impact of inappropriate cellulitis tests?

  • CDC breaks down HIV incidence, prevalence among MSM

  • HHS launches new initiative to boost patient medical record access

April 4, 2018:

  • Deadline approaching: Review your Sunshine Act info

  • New Medicare card transition to begin this month

  • FDA seeks methods to improve biosimilar pathway

  • iPLEDGE REMS program website experiencing issues

  • Wife of Surgeon General undergoing surgery for recurrent metastatic melanoma

  • New: Guidelines for evaluating hirsutism

  • Does weight affect onychomycosis risk?

March 21 & March 28, 2018

March 28, 2018:

  • The burden of prior authorizations: Is it really that bad?

  • Take the ABMS survey on MOC

  • Help wanted: AAD Pruritus Measure Testing Project

  • FDA approves new psoriasis biologic

  • Health care cyberattacks on the rise

  • When do copayments cost more than drugs? Fairly often, study shows.

March 21, 2018:

  • Walgreens sued over generic drug prices

  • March Access Hero: Dr. Chong

  • Help wanted: AAD Pruritus Measure Testing Project

  • Deadline for 2017 MIPS data submission

  • New poll shows patient-physician communication disconnect

  • USPSTF issues recommendations on skin cancer prevention counseling

  • Help AADA, AMA rein in burdensome regulations, harmful payer policies

March 7 & March 14, 2018

March 14, 2018:

  • FDA approves anti-fungal agent for pediatric patients

  • Bruce H. Thiers, MD, elected incoming president-elect

  • Open Payments review starts next month: Are you ready?

  • Melanoma incidence among young, white women declines drastically

  • New Medicare cards: Educate your patients while they wait

  • FDA to inspect Cantrell Drug Co. compounding facility

  • Pulse check: How are EHR systems faring on interoperability?

March 7, 2018:

  • Is MIPS a burden? Tell CMS and get full credit in 2018.

  • Academy election results announced

  • ABD requests Mohs subspecialty certification

  • AAD relocates headquarters

  • Conversion therapy still common for LGBT population

Feb. 21 & Feb. 28, 2018

Feb. 28, 2018:

  • Another win for dermatology: Anthem rescinds proposed modifier 25 policy

  • Vote in the AAD election by March 3

  • FDA grants rituximab priority review for pemphigus vulgaris

  • CMS eases up on value-based payment focus

  • Do EHRs reduce administrative costs?

  • Laser treatment may improve nail psoriasis severity

Feb. 21, 2018:

  • CMS releases MIPS quality performance scores

  • AAD election

  • Study indicates e-consults improve access to dermatology

  • How helpful is federal research funding?

  • Water systems tainted for many Americans

Feb. 7 & Feb. 14, 2018

Feb. 14, 2018:

  • A win for dermatology: Congress repeals IPAB, stops misvalued codes policy

  • Vote in the AAD election by March 3

  • Are machines poised to replace physicians?

  • Countdown to official Medicare card transition

  • Do pediatric psoriasis patients have a greater risk of developing obesity?

Feb. 7, 2018:

  • Generic drug prices: What to expect in 2018

  • February Access Hero: Dr. Brodell

  • CMS expands ‘Extreme and Uncontrollable Circumstances’ policy

  • Network inaccuracies worsen

  • Fewer physicians opting out of Medicare

Jan. 24 & Jan. 31, 2018

Jan. 31, 2018:

  • First IGA scale for EB simplex validated

  • AAD election candidates announced

  • FDA to revise draft guidance affecting in-office preparations

  • How do different SPFs compare?

  • Alex Azar confirmed as HHS Secretary

  • NMQF accepting nominations for Leaders in Minority Health Awards

Jan. 24, 2018:

  • Psoriasis treatments: Which ones are the most effective?

  • AAD names Dirk Elston, MD, next JAAD editor

  • SCC death reports may be inaccurate

  • Does adherence vary by treatment?

  • Where are the tanning salons?

Jan. 3, Jan. 10 & Jan. 17, 2018

Jan. 17, 2018:

  • How does the new tax reform law affect your practice?

  • HHS 2018 regulatory agenda includes sunscreen, sunlamps

  • Patients sue health insurer

  • New Advanced APM approved

Jan. 10, 2018:

  • Academy releases new NMSC clinical guidelines

  • Stem cell transplants for scleroderma patients may improve survival, quality of life

  • CMS launches new QPP data submission program

  • Drug approvals: FDA steps on the gas

  • AD drug receives FDA breakthrough therapy status

Jan. 3, 2018:

  • Anthem delays, changes modifier 25 cuts

  • FDA approves PD-1 inhibitor for melanoma

  • Spending on drugs slowed in 2016

  • Countdown to Medicare card transition begins

  • Health care discrepancies may exist for Native Americans

Additional Dermatology World Resources